Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Impaired Immune Health in Survivors of Diffuse Large B-Cell Lymphoma.

Shree T, Li Q, Glaser SL, Brunson A, Maecker HT, Haile RW, Levy R, Keegan THM.

J Clin Oncol. 2020 Feb 21:JCO1901937. doi: 10.1200/JCO.19.01937. [Epub ahead of print]

PMID:
32083991
2.

Erratum: Author Correction: Breast-cancer-specific mortality in patients treated based on the 21-gene assay: a SEER population-based study.

Petkov VI, Miller DP, Howlader N, Gliner N, Howe W, Schussler N, Cronin K, Baehner FL, Cress R, Deapen D, Glaser SL, Hernandez BY, Lynch CF, Mueller L, Schwartz AG, Schwartz SM, Stroup A, Sweeney C, Tucker TC, Ward KC, Wiggins C, Wu XC, Penberthy L, Shak S.

NPJ Breast Cancer. 2018 Jul 6;4:17. doi: 10.1038/s41523-018-0069-3. eCollection 2018.

3.

Sociodemographic disparities in the occurrence of medical conditions among adolescent and young adult Hodgkin lymphoma survivors.

Keegan THM, Li Q, Steele A, Alvarez EM, Brunson A, Flowers CR, Glaser SL, Wun T.

Cancer Causes Control. 2018 Jun;29(6):551-561. doi: 10.1007/s10552-018-1025-0. Epub 2018 Apr 13.

4.

Continued Increase in Melanoma Incidence across all Socioeconomic Status Groups in California, 1998-2012.

Clarke CA, McKinley M, Hurley S, Haile RW, Glaser SL, Keegan THM, Swetter SM.

J Invest Dermatol. 2017 Nov;137(11):2282-2290. doi: 10.1016/j.jid.2017.06.024. Epub 2017 Jul 21.

5.

Breast-cancer-specific mortality in patients treated based on the 21-gene assay: a SEER population-based study.

Petkov VI, Miller DP, Howlader N, Gliner N, Howe W, Schussler N, Cronin K, Baehner FL, Cress R, Deapen D, Glaser SL, Hernandez BY, Lynch CF, Mueller L, Schwartz AG, Schwartz SM, Stroup A, Sweeney C, Tucker TC, Ward KC, Wiggins C, Wu XC, Penberthy L, Shak S.

NPJ Breast Cancer. 2016 Jun 8;2:16017. doi: 10.1038/npjbcancer.2016.17. eCollection 2016. Erratum in: NPJ Breast Cancer. 2018 Jul 6;4:17.

6.

Breast cancer in Asian Americans in California, 1988-2013: increasing incidence trends and recent data on breast cancer subtypes.

Gomez SL, Von Behren J, McKinley M, Clarke CA, Shariff-Marco S, Cheng I, Reynolds P, Glaser SL.

Breast Cancer Res Treat. 2017 Jul;164(1):139-147. doi: 10.1007/s10549-017-4229-1. Epub 2017 Apr 1.

7.

Variation in risk and outcomes of Epstein-Barr virus-associated breast cancer by epidemiologic characteristics and virus detection strategies: an exploratory study.

Glaser SL, Canchola AJ, Keegan TH, Clarke CA, Longacre TA, Gulley ML.

Cancer Causes Control. 2017 Apr;28(4):273-287. doi: 10.1007/s10552-017-0865-3. Epub 2017 Feb 22.

PMID:
28229344
8.

Recent declines in cancer incidence: related to the Great Recession?

Gomez SL, Canchola AJ, Nelson DO, Keegan TH, Clarke CA, Cheng I, Shariff-Marco S, DeRouen M, Catalano R, Satariano WA, Davidson-Allen K, Glaser SL.

Cancer Causes Control. 2017 Feb;28(2):145-154. doi: 10.1007/s10552-016-0846-y. Epub 2017 Jan 27.

PMID:
28130633
9.

Prevalence and characteristics of cancer patients receiving care from single vs. multiple institutions.

Clarke CA, Glaser SL, Leung R, Davidson-Allen K, Gomez SL, Keegan TH.

Cancer Epidemiol. 2017 Feb;46:27-33. doi: 10.1016/j.canep.2016.11.001. Epub 2016 Dec 3.

10.

Differences in marital status and mortality by race/ethnicity and nativity among California cancer patients.

Martínez ME, Anderson K, Murphy JD, Hurley S, Canchola AJ, Keegan TH, Cheng I, Clarke CA, Glaser SL, Gomez SL.

Cancer. 2016 May 15;122(10):1570-8. doi: 10.1002/cncr.29886. Epub 2016 Apr 11.

11.

Effects of marital status and economic resources on survival after cancer: A population-based study.

Gomez SL, Hurley S, Canchola AJ, Keegan TH, Cheng I, Murphy JD, Clarke CA, Glaser SL, Martínez ME.

Cancer. 2016 May 15;122(10):1618-25. doi: 10.1002/cncr.29885. Epub 2016 Apr 11.

12.

Meta-analysis of genome-wide association studies reveals genetic overlap between Hodgkin lymphoma and multiple sclerosis.

Khankhanian P, Cozen W, Himmelstein DS, Madireddy L, Din L, van den Berg A, Matsushita T, Glaser SL, Moré JM, Smedby KE, Baranzini SE, Mack TM, Lizée A, de Sanjosé S, Gourraud PA, Nieters A, Hauser SL, Cocco P, Maynadié M, Foretová L, Staines A, Delahaye-Sourdeix M, Li D, Bhatia S, Melbye M, Onel K, Jarrett R, McKay JD, Oksenberg JR, Hjalgrim H.

Int J Epidemiol. 2016 Jun;45(3):728-40. doi: 10.1093/ije/dyv364. Epub 2016 Mar 12.

13.

Impact of Treatment and Insurance on Socioeconomic Disparities in Survival after Adolescent and Young Adult Hodgkin Lymphoma: A Population-Based Study.

Keegan TH, DeRouen MC, Parsons HM, Clarke CA, Goldberg D, Flowers CR, Glaser SL.

Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):264-73. doi: 10.1158/1055-9965.EPI-15-0756. Epub 2016 Jan 29.

14.

Time Trends in Rates of Hodgkin Lymphoma Histologic Subtypes: True Incidence Changes or Evolving Diagnostic Practice?

Glaser SL, Clarke CA, Keegan TH, Chang ET, Weisenburger DD.

Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1474-88. doi: 10.1158/1055-9965.EPI-15-0281. Epub 2015 Jul 27.

15.

Family history of cancer and risk of pediatric and adolescent Hodgkin lymphoma: A Children's Oncology Group study.

Linabery AM, Erhardt EB, Richardson MR, Ambinder RF, Friedman DL, Glaser SL, Monnereau A, Spector LG, Ross JA, Grufferman S.

Int J Cancer. 2015 Nov 1;137(9):2163-74. doi: 10.1002/ijc.29589. Epub 2015 May 19.

16.

Hodgkin lymphoma incidence in ethnic enclaves in California.

Glaser SL, Chang ET, Clarke CA, Keegan TH, Yang J, Gomez SL.

Leuk Lymphoma. 2015;56(12):3270-80. doi: 10.3109/10428194.2015.1026815. Epub 2015 Jun 18.

17.

Racial/ethnic and socioeconomic disparities in survival among children with acute lymphoblastic leukemia in California, 1988-2011: A population-based observational study.

Abrahão R, Lichtensztajn DY, Ribeiro RC, Marina NM, Keogh RH, Marcos-Gragera R, Glaser SL, Keegan TH.

Pediatr Blood Cancer. 2015 Oct;62(10):1819-25. doi: 10.1002/pbc.25544. Epub 2015 Apr 20.

PMID:
25894846
18.

The impact of neighborhood social and built environment factors across the cancer continuum: Current research, methodological considerations, and future directions.

Gomez SL, Shariff-Marco S, DeRouen M, Keegan TH, Yen IH, Mujahid M, Satariano WA, Glaser SL.

Cancer. 2015 Jul 15;121(14):2314-30. doi: 10.1002/cncr.29345. Epub 2015 Apr 6. Review.

19.

Cancer research in Asian American, Native Hawaiian, and Pacific Islander populations: accelerating cancer knowledge by acknowledging and leveraging heterogeneity.

Gomez SL, Glaser SL, Horn-Ross PL, Cheng I, Quach T, Clarke CA, Reynolds P, Shariff-Marco S, Yang J, Lee MM, Satariano WA, Hsing AW.

Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2202-5. doi: 10.1158/1055-9965.EPI-14-0624.

20.

A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.

Cozen W, Timofeeva MN, Li D, Diepstra A, Hazelett D, Delahaye-Sourdeix M, Edlund CK, Franke L, Rostgaard K, Van Den Berg DJ, Cortessis VK, Smedby KE, Glaser SL, Westra HJ, Robison LL, Mack TM, Ghesquieres H, Hwang AE, Nieters A, de Sanjose S, Lightfoot T, Becker N, Maynadie M, Foretova L, Roman E, Benavente Y, Rand KA, Nathwani BN, Glimelius B, Staines A, Boffetta P, Link BK, Kiemeney L, Ansell SM, Bhatia S, Strong LC, Galan P, Vatten L, Habermann TM, Duell EJ, Lake A, Veenstra RN, Visser L, Liu Y, Urayama KY, Montgomery D, Gaborieau V, Weiss LM, Byrnes G, Lathrop M, Cocco P, Best T, Skol AD, Adami HO, Melbye M, Cerhan JR, Gallagher A, Taylor GM, Slager SL, Brennan P, Coetzee GA, Conti DV, Onel K, Jarrett RF, Hjalgrim H, van den Berg A, McKay JD.

Nat Commun. 2014 Jun 12;5:3856. doi: 10.1038/ncomms4856.

21.

Hodgkin lymphoma incidence in California Hispanics: influence of nativity and tumor Epstein-Barr virus.

Glaser SL, Clarke CA, Chang ET, Yang J, Gomez SL, Keegan TH.

Cancer Causes Control. 2014 Jun;25(6):709-25. doi: 10.1007/s10552-014-0374-6. Epub 2014 Apr 11.

22.

Response to Evens et al., racial disparities in Hodgkin's lymphoma: a comprehensive population-based analysis, Annals of Oncology 23: 2128-2137, 2012.

Glaser SL, Clarke CA, Gomez SL.

Ann Oncol. 2013 Dec;24(12):3136. doi: 10.1093/annonc/mdt487. No abstract available.

23.

Exposure to UV radiation and risk of Hodgkin lymphoma: a pooled analysis.

Monnereau A, Glaser SL, Schupp CW, Ekström Smedby K, de Sanjosé S, Kane E, Melbye M, Forétova L, Maynadié M, Staines A, Becker N, Nieters A, Brennan P, Boffetta P, Cocco P, Glimelius I, Clavel J, Hjalgrim H, Chang ET.

Blood. 2013 Nov 14;122(20):3492-9. doi: 10.1182/blood-2013-04-497586. Epub 2013 Sep 9.

24.

Cigarette smoking and risk of Hodgkin lymphoma and its subtypes: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph).

Kamper-Jørgensen M, Rostgaard K, Glaser SL, Zahm SH, Cozen W, Smedby KE, Sanjosé S, Chang ET, Zheng T, La Vecchia C, Serraino D, Monnereau A, Kane EV, Miligi L, Vineis P, Spinelli JJ, McLaughlin JR, Pahwa P, Dosman JA, Vornanen M, Foretova L, Maynadie M, Staines A, Becker N, Nieters A, Brennan P, Boffetta P, Cocco P, Hjalgrim H.

Ann Oncol. 2013 Sep;24(9):2245-55. doi: 10.1093/annonc/mdt218. Epub 2013 Jun 19. Review.

25.

Rituximab use and survival after diffuse large B-cell or follicular lymphoma: a population-based study.

Keegan TH, Moy LM, Foran JM, Alizadeh AA, Chang ET, Shema SJ, Schupp CW, Clarke CA, Glaser SL.

Leuk Lymphoma. 2013 Apr;54(4):743-51. doi: 10.3109/10428194.2012.727415. Epub 2012 Sep 28.

PMID:
22957852
26.

Gastric cancer incidence among Hispanics in California: patterns by time, nativity, and neighborhood characteristics.

Chang ET, Gomez SL, Fish K, Schupp CW, Parsonnet J, DeRouen MC, Keegan TH, Clarke CA, Glaser SL.

Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):709-19. doi: 10.1158/1055-9965.EPI-11-1208. Epub 2012 Feb 28.

27.

A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32.

Cozen W, Li D, Best T, Van Den Berg DJ, Gourraud PA, Cortessis VK, Skol AD, Mack TM, Glaser SL, Weiss LM, Nathwani BN, Bhatia S, Schumacher FR, Edlund CK, Hwang AE, Slager SL, Fredericksen ZS, Strong LC, Habermann TM, Link BK, Cerhan JR, Robison LL, Conti DV, Onel K.

Blood. 2012 Jan 12;119(2):469-75. doi: 10.1182/blood-2011-03-343921. Epub 2011 Nov 15.

28.

Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger.

Gaudet MM, Press MF, Haile RW, Lynch CF, Glaser SL, Schildkraut J, Gammon MD, Douglas Thompson W, Bernstein JL.

Breast Cancer Res Treat. 2011 Nov;130(2):587-97. doi: 10.1007/s10549-011-1616-x. Epub 2011 Jun 11.

29.

Lymphoid malignancies in U.S. Asians: incidence rate differences by birthplace and acculturation.

Clarke CA, Glaser SL, Gomez SL, Wang SS, Keegan TH, Yang J, Chang ET.

Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1064-77. doi: 10.1158/1055-9965.EPI-11-0038. Epub 2011 Apr 14.

30.

The California Neighborhoods Data System: a new resource for examining the impact of neighborhood characteristics on cancer incidence and outcomes in populations.

Gomez SL, Glaser SL, McClure LA, Shema SJ, Kealey M, Keegan TH, Satariano WA.

Cancer Causes Control. 2011 Apr;22(4):631-47. doi: 10.1007/s10552-011-9736-5. Epub 2011 Feb 12.

31.

The influence of nativity and neighborhoods on breast cancer stage at diagnosis and survival among California Hispanic women.

Keegan TH, Quach T, Shema S, Glaser SL, Gomez SL.

BMC Cancer. 2010 Nov 4;10:603. doi: 10.1186/1471-2407-10-603.

32.

Disparities in liver cancer incidence by nativity, acculturation, and socioeconomic status in California Hispanics and Asians.

Chang ET, Yang J, Alfaro-Velcamp T, So SK, Glaser SL, Gomez SL.

Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):3106-18. doi: 10.1158/1055-9965.EPI-10-0863. Epub 2010 Oct 12.

33.

Disparities in breast cancer survival among Asian women by ethnicity and immigrant status: a population-based study.

Gomez SL, Clarke CA, Shema SJ, Chang ET, Keegan TH, Glaser SL.

Am J Public Health. 2010 May;100(5):861-9. doi: 10.2105/AJPH.2009.176651. Epub 2010 Mar 18.

34.

Are cancer registries unconstitutional?

McLaughlin RH, Clarke CA, Crawley LM, Glaser SL.

Soc Sci Med. 2010 May;70(9):1295-300. doi: 10.1016/j.socscimed.2010.01.032. Epub 2010 Feb 12.

35.

Increasing mastectomy rates for early-stage breast cancer? Population-based trends from California.

Gomez SL, Lichtensztajn D, Kurian AW, Telli ML, Chang ET, Keegan TH, Glaser SL, Clarke CA.

J Clin Oncol. 2010 Apr 1;28(10):e155-7; author reply e158. doi: 10.1200/JCO.2009.26.1032. Epub 2010 Feb 16. No abstract available.

36.

Hidden breast cancer disparities in Asian women: disaggregating incidence rates by ethnicity and migrant status.

Gomez SL, Quach T, Horn-Ross PL, Pham JT, Cockburn M, Chang ET, Keegan TH, Glaser SL, Clarke CA.

Am J Public Health. 2010 Apr 1;100 Suppl 1:S125-31. doi: 10.2105/AJPH.2009.163931. Epub 2010 Feb 10.

37.

Availability and accuracy of medical record information on language usage of cancer patients from a multi-ethnic population.

McClure LA, Glaser SL, Shema SJ, Allen L, Quesenberry C, John EM, Gomez SL.

J Immigr Minor Health. 2010 Aug;12(4):480-8. doi: 10.1007/s10903-009-9282-3.

38.

Recent trends in breast cancer incidence in US white women by county-level urban/rural and poverty status.

Hausauer AK, Keegan TH, Chang ET, Glaser SL, Howe H, Clarke CA.

BMC Med. 2009 Jun 26;7:31. doi: 10.1186/1741-7015-7-31.

39.

Disparities in survival after Hodgkin lymphoma: a population-based study.

Keegan TH, Clarke CA, Chang ET, Shema SJ, Glaser SL.

Cancer Causes Control. 2009 Dec;20(10):1881-92. doi: 10.1007/s10552-009-9382-3.

40.

Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California populations.

Glaser SL, Gulley ML, Clarke CA, Keegan TH, Chang ET, Shema SJ, Craig FE, Digiuseppe JA, Dorfman RF, Mann RB, Anton-Culver H, Ambinder RF.

Int J Cancer. 2008 Oct 1;123(7):1499-507. doi: 10.1002/ijc.23741.

41.

Incidence of lymphoid neoplasms by subtype among six Asian ethnic groups in the United States, 1996-2004.

Carreon JD, Morton LM, Devesa SS, Clarke CA, Gomez SL, Glaser SL, Sakoda LC, Linet MS, Wang SS.

Cancer Causes Control. 2008 Dec;19(10):1171-81. doi: 10.1007/s10552-008-9184-z. Epub 2008 Jun 10.

42.

Availability and utility of body mass index for population-based cancer surveillance.

Keegan TH, Le GM, McClure LA, Glaser SL.

Cancer Causes Control. 2008 Feb;19(1):51-7. Epub 2007 Oct 18.

43.

Declines in breast cancer after the WHI: apparent impact of hormone therapy.

Clarke CA, Glaser SL.

Cancer Causes Control. 2007 Oct;18(8):847-52. Epub 2007 Jul 6. Review.

PMID:
17619153
44.
45.

The burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay Area, 1990 through 2004.

Chang ET, Keegan TH, Gomez SL, Le GM, Clarke CA, So SK, Glaser SL.

Cancer. 2007 May 15;109(10):2100-8.

46.

Making sense of seasonal fluctuations in lymphoma diagnosis.

Chang ET, Clarke CA, Glaser SL.

Leuk Lymphoma. 2007 Feb;48(2):223-4. No abstract available.

PMID:
17325879
47.

Recent changes in breast cancer incidence and risk factor prevalence in San Francisco Bay area and California women: 1988 to 2004.

Keegan TH, Chang ET, John EM, Horn-Ross PL, Wrensch MR, Glaser SL, Clarke CA.

Breast Cancer Res. 2007;9(5):R62. doi: 10.1186/bcr1768. Epub 2007 Sep 25.

48.

Recent trends in breast cancer incidence among 6 Asian groups in the Greater Bay Area of Northern California.

Keegan TH, Gomez SL, Clarke CA, Chan JK, Glaser SL.

Int J Cancer. 2007 Mar 15;120(6):1324-9.

49.

Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence.

Clarke CA, Glaser SL, Uratsu CS, Selby JV, Kushi LH, Herrinton LJ.

J Clin Oncol. 2006 Nov 20;24(33):e49-50. No abstract available.

PMID:
17114650
50.

Supplemental Content

Loading ...
Support Center